Joint Development with Fuji Pharma
Women's Health product candidates
Not DisclosedActive
Key Facts
About Gedeon Richter
Gedeon Richter is a century-old, publicly traded European pharmaceutical company with a strong foundation in generic drugs and a strategic pivot towards innovative therapeutics, particularly in Women's Health. The company is actively expanding its innovative pipeline through internal R&D and strategic acquisitions, such as the Celmatix discovery portfolio, and partnerships, like the recent joint development agreement with Fuji Pharma. With a commercial footprint in over 100 countries and a significant R&D investment, Richter is transitioning from a generics-focused player to an innovation-driven specialty pharma company, as evidenced by recent European Commission approvals for novel products like FYLREVY®.
View full company profile